17-OHPC in Pregnancy: IM vs SC Routes
Terminated
- Conditions
- Preterm Birth
- Interventions
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2023-08-03
- Lead Sponsor
- Steve N. Caritis, MD
- Target Recruit Count
- 24
- Registration Number
- NCT04183452
- Locations
- ๐บ๐ธ
University of Pittsburgh-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
๐บ๐ธChristiana Care, Newark, Delaware, United States
๐บ๐ธDuke University Medical Center, Durham, North Carolina, United States
Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy
Phase 2
Terminated
- Conditions
- PregnancyOpiate Addiction
- Interventions
- Drug: Frequency GroupDrug: Magnitude Group
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Steve N. Caritis, MD
- Target Recruit Count
- 13
- Registration Number
- NCT03831113
- Locations
- ๐บ๐ธ
Univerity of Pittsburgh Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
๐บ๐ธHigh Risk Obstetrical Consultants, Knoxville, Tennessee, United States
Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth
Phase 1
Terminated
- Conditions
- Preterm Birth
- Interventions
- Drug: Safety study of 500 mg dose.
- First Posted Date
- 2017-09-26
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Steve N. Caritis, MD
- Target Recruit Count
- 159
- Registration Number
- NCT03292731
- Locations
- ๐บ๐ธ
University of Utah, Salt Lake City, Utah, United States
๐บ๐ธNorthwestern University, Chicago, Illinois, United States
๐บ๐ธUniversity of Texas Medical Branch, Galveston, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath